查看購物車
  • Simplified Chinese
  • English
中東和非洲肌肉減少症治療市場預測至 2030 年 - 區域分析 - 按治療類型和配銷通路
市場調查報告書
商品編碼
1562370

中東和非洲肌肉減少症治療市場預測至 2030 年 - 區域分析 - 按治療類型和配銷通路

Middle East & Africa Sarcopenia Treatment Market Forecast to 2030 - Regional Analysis - by Treatment Type and Distribution Channel
出版日期: | 出版商: The Insight Partners | 英文 70 Pages | 訂單完成後即時交付

價格

2022年中東和非洲肌肉減少症治療市場價值為6,659萬美元，預計到2030年將達到9,055萬美元；預計2022年至2030年複合年成長率為3.9%。

人們對肌少症的認知不斷提高，促進了中東和非洲肌少症治療市場

人們對肌少症及其對健康的負面影響的認知不斷提高，為醫療保健和老年護理領域的進步提供了廣闊的空間。許多計劃團體和組織正在積極採取措施，提高群眾對肌少症的認知。這些組織經常與醫療專業人員合作，讓大眾了解某些疾病的各個方面的最新情況，例如致病性、目標患者、預防和治療，並強調及時診斷和治療的價值。根據 OWH 的「強於肌少症」運動，敦促女性與醫療保健提供者討論肌少症，然後接受疾病篩檢，並在需要時採取適當的治療。

肌少症已被納入醫學院的課程和針對醫生、護士和物理治療師等醫療保健專業人員的培訓計劃。例如，OWH 與 Medscape Education 合作，為醫療保健專業人員創建繼續醫學教育 (CME) 學分，這將使他們能夠更好地檢測和治療患者的肌肉減少症。主流媒體已擴大對肌少症的報導，包括文章、新聞報導和紀錄片。因此，人們對肌少症認知的提高可能會在未來幾年為肌少症治療市場帶來新的成長趨勢。

中東和非洲肌少症治療市場概述

中東和非洲肌少症治療市場分為沙烏地阿拉伯、阿拉伯聯合大公國、南非和中東和非洲其他地區。由於骨科疾病發生率不斷上升，阿拉伯聯合大公國和沙烏地阿拉伯是市場最重要的貢獻者之一。提高廣大人口對營養補充劑的使用和益處的認知也有利於市場的進步。

南非肌少症風險的增加與人口老化以及貧窮導致的糧食安全和營養攝取不足有關。預計該國的肌少症治療市場將受到衛生當局為診斷、治療和預防肌少症而採取的獨特的針對特定人群的方法的推動。

中東及非洲肌肉減少症治療市場收入及 2030 年預測（百萬美元）

中東和非洲肌少症治療市場區隔

中東和非洲肌少症治療市場按治療類型、配銷通路和國家分類。

根據治療類型，中東和非洲肌少症治療市場分為維生素 D 和鈣補充劑、蛋白質補充劑、維生素 B12 補充劑等。 2022 年，維生素 D 和鈣補充劑領域佔據中東和非洲肌肉減少症治療市場最大佔有率。

在配銷通路方面，中東和非洲肌少症治療市場分為藥局、零售通路、線上通路等。 2022 年，藥局細分市場佔據中東和非洲肌肉減少症治療市場最大佔有率。

按國家/地區分類，中東和非洲肌少症治療市場分為沙烏地阿拉伯、南非、阿拉伯聯合大公國以及中東和非洲其他地區。 2022 年，南非在中東和非洲肌肉減少症治療市場佔有率中佔據主導地位。

雅培實驗室、拜耳公司、雀巢健康科學公司、諾華公司、輝瑞公司、賽諾菲公司、安麗公司和葛蘭素史克公司是中東和非洲肌少症治療市場的一些領先公司。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 主要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：中東和非洲肌肉減少症治療市場 - 主要產業動態

  • 中東和非洲肌少症治療市場 - 主要產業動態
  • 市場促進因素
    • 老年人口激增
    • 成人營養不良和維生素缺乏症增加
  • 主要市場限制：
    • 無法直接干預
  • 主要市場機會：
    • 處於臨床試驗階段的產品
  • 未來趨勢：
    • 人們對肌少症的認知不斷提高
  • 促進因素和限制的影響：

第 5 章：肌少症治療市場 - 中東和非洲市場分析

  • 中東和非洲肌少症治療市場收入，2020 - 2030
  • 中東與非洲肌少症治療市場預測與分析

第 6 章：中東和非洲肌肉減少症治療市場分析 - 按治療類型

  • 維生素 D 和鈣補充劑
  • 蛋白質補充劑
  • 維生素 B12 補充劑
  • 其他

第 7 章：中東和非洲肌肉減少症治療市場分析 - 按配銷通路

  • 藥局
  • 零售通路
  • 線上通路
  • 其他

第 8 章：中東和非洲肌肉減少症治療市場 - 國家分析

  • 中東和非洲
    • 南
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 9 章：肌少症治療市場-產業格局

  • 概述
  • 肌少症治療市場的成長策略
  • 無機成長策略
    • 概述
  • 有機成長策略
    • 概述

第 10 章：公司簡介

  • Abbott Laboratories
  • Bayer AG
  • Nestle Health Science SA
  • Novartis AG
  • Pfizer Inc
  • Sanofi SA
  • Amway Corp
  • GSK Plc

第 11 章：附錄

Product Code: BMIRE00030473

The Middle East & Africa sarcopenia treatment market was valued at US$ 66.59 million in 2022 and is expected to reach US$ 90.55 million by 2030; it is estimated to register a CAGR of 3.9% from 2022 to 2030.

Rising Awareness About Sarcopenia Bolster Middle East & Africa Sarcopenia Treatment Market

The growing awareness of sarcopenia and its negative impact on health presents a significant scope for advancements in the fields of healthcare and geriatric care. Many advocacy groups and organizations are proactively taking steps to raise the awareness of sarcopenia among the masses. These organizations often work with medical professionals to keep the public updated on the various aspects of certain disorders, such as pathogenicity, target patients, prevention, and treatments, along with underlining the value of prompt diagnosis and treatment. In line with OWH's "Stronger than Sarcopenia" campaign, women are urged to discuss sarcopenia with their healthcare providers, followed by undergoing screen for the illness and taking appropriate therapy if required.

Sarcopenia has been included in the curricula of medical schools and training programs for healthcare professionals such as physicians, nurses, and physical therapists. For example, the OWH worked with Medscape Education to create continuing medical education (CME) credits for healthcare professionals, which will better equip them to detect and treat sarcopenia in their patients. Mainstream media has expanded its coverage of sarcopenia to include articles, news stories, and documentaries. Thus, the elevating awareness regarding sarcopenia is likely to bring new growth trends into the sarcopenia treatment market in the coming years.

Middle East & Africa Sarcopenia Treatment Market Overview

The Middle East & Africa sarcopenic treatment market is segmented into Saudi Arabia, the UAE, South Africa, and the Rest of MEA. The UAE and Saudi Arabia are among the most significant contributors to the market due to the rising incidence of orthopedic disorders. Increasing awareness among the large population about the use and benefits of nutritional supplements also benefits the market progress.

An increased risk of sarcopenia in South Africa is associated with the aging population, and inadequate food security and nutrient intake brought on by poverty. The sarcopenia treatment market in this country is anticipated to be driven by a distinct population-specific approach taken by health authorities for the diagnosis, treatment, and prevention of sarcopenia.

Middle East & Africa Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)

Middle East & Africa Sarcopenia Treatment Market Segmentation

The Middle East & Africa sarcopenia treatment market is categorized into treatment type, distribution channel, and country.

Based on treatment type, the Middle East & Africa sarcopenia treatment market is segmented into vitamin D and calcium supplement, protein supplement, vitamin B12 supplement, and others. The vitamin D and calcium supplement segment held the largest Middle East & Africa sarcopenia treatment market share in 2022.

In terms of distribution channel, the Middle East & Africa sarcopenia treatment market is segmented into pharmacies, retail channels, online channels, and others. The pharmacies segment held the largest Middle East & Africa sarcopenia treatment market share in 2022.

By country, the Middle East & Africa sarcopenia treatment market is segmented into Saudia Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. South Africa dominated the Middle East & Africa sarcopenia treatment market share in 2022.

Abbott Laboratories, Bayer AG, Nestle Health Science SA, Novartis AG, Pfizer Inc, Sanofi SA, Amway Corp, and GSK Plc are some of the leading companies operating in the Middle East & Africa sarcopenia treatment market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Middle East & Africa Sarcopenia Treatment Market - Key Industry Dynamics

  • 4.1 Middle East & Africa Sarcopenia Treatment Market - Key Industry Dynamics
  • 4.2 Market Drivers
    • 4.2.1 Upsurge in Geriatric Population
    • 4.2.2 Rise in Malnutrition and Vitamin Deficiency Among Adults
  • 4.3 Key Market Restraints:
    • 4.3.1 Unavailability of Direct Interventions
  • 4.4 Key Market Opportunities:
    • 4.4.1 Products in Clinical Trial Phases
  • 4.5 Future Trends:
    • 4.5.1 Rising Awareness About Sarcopenia
  • 4.6 Impact of Drivers and Restraints:

5. Sarcopenia Treatment Market - Middle East & Africa Market Analysis

  • 5.1 Middle East & Africa Sarcopenia Treatment Market Revenue (US$ Million), 2020 - 2030
  • 5.2 Middle East & Africa Sarcopenia Treatment Market Forecast and Analysis

6. Middle East & Africa Sarcopenia Treatment Market Analysis - By Treatment Type

  • 6.1 Vitamin D and Calcium Supplement
    • 6.1.1 Overview
    • 6.1.2 Vitamin D and Calcium Supplement: Middle East & Africa Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.2 Protein Supplement
    • 6.2.1 Overview
    • 6.2.2 Protein Supplement : Middle East & Africa Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.3 Vitamin B12 Supplement
    • 6.3.1 Overview
    • 6.3.2 Vitamin B12 Supplement: Middle East & Africa Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Others
    • 6.4.1 Overview
    • 6.4.2 Others : Middle East & Africa Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)

7. Middle East & Africa Sarcopenia Treatment Market Analysis - By Distribution Channel

  • 7.1 Pharmacies
    • 7.1.1 Overview
    • 7.1.2 Pharmacies : Middle East & Africa Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)
  • 7.2 Retail Channels
    • 7.2.1 Overview
    • 7.2.2 Retail Channels : Middle East & Africa Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Online Channels
    • 7.3.1 Overview
    • 7.3.2 Online Channels : Middle East & Africa Sarcopenia Treatment Market, Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Others
    • 7.4.1 Overview
    • 7.4.2 Others : Middle East & Africa Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)

8. Middle East & Africa Sarcopenia Treatment Market - Country Analysis

  • 8.1 Middle East & Africa
    • 8.1.1 Middle East & Africa Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
      • 8.1.1.1 Middle East & Africa Sarcopenia Treatment Market Revenue and Forecast and Analysis - By Country
      • 8.1.1.2 South Africa Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 8.1.1.2.1 South Africa Sarcopenia Treatment Market Breakdown by Treatment Type
        • 8.1.1.2.2 South Africa Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 8.1.1.3 Saudi Arabia Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 8.1.1.3.1 Saudi Arabia Sarcopenia Treatment Market Breakdown by Treatment Type
        • 8.1.1.3.2 Saudi Arabia Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 8.1.1.4 United Arab Emirates Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 8.1.1.4.1 United Arab Emirates Sarcopenia Treatment Market Breakdown by Treatment Type
        • 8.1.1.4.2 United Arab Emirates Sarcopenia Treatment Market Breakdown by Distribution Channel
      • 8.1.1.5 Rest of Middle East & Africa Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 8.1.1.5.1 Rest of Middle East & Africa Sarcopenia Treatment Market Breakdown by Treatment Type
        • 8.1.1.5.2 Rest of Middle East & Africa Sarcopenia Treatment Market Breakdown by Distribution Channel

9. Sarcopenia Treatment Market-Industry Landscape

  • 9.1 Overview
  • 9.2 Growth Strategies in the Sarcopenia Treatment Market
  • 9.3 Inorganic Growth Strategies
    • 9.3.1 Overview
  • 9.4 Organic Growth Strategies
    • 9.4.1 Overview

10. Company Profiles

  • 10.1 Abbott Laboratories
    • 10.1.1 Key Facts
    • 10.1.2 Business Description
    • 10.1.3 Products and Services
    • 10.1.4 Financial Overview
    • 10.1.5 SWOT Analysis
    • 10.1.6 Key Developments
  • 10.2 Bayer AG
    • 10.2.1 Key Facts
    • 10.2.2 Business Description
    • 10.2.3 Products and Services
    • 10.2.4 Financial Overview
    • 10.2.5 SWOT Analysis
    • 10.2.6 Key Developments
  • 10.3 Nestle Health Science SA
    • 10.3.1 Key Facts
    • 10.3.2 Business Description
    • 10.3.3 Products and Services
    • 10.3.4 Financial Overview
    • 10.3.5 SWOT Analysis
    • 10.3.6 Key Developments
  • 10.4 Novartis AG
    • 10.4.1 Key Facts
    • 10.4.2 Business Description
    • 10.4.3 Products and Services
    • 10.4.4 Financial Overview
    • 10.4.5 SWOT Analysis
    • 10.4.6 Key Developments
  • 10.5 Pfizer Inc
    • 10.5.1 Key Facts
    • 10.5.2 Business Description
    • 10.5.3 Products and Services
    • 10.5.4 Financial Overview
    • 10.5.5 SWOT Analysis
    • 10.5.6 Key Developments
  • 10.6 Sanofi SA
    • 10.6.1 Key Facts
    • 10.6.2 Business Description
    • 10.6.3 Products and Services
    • 10.6.4 Financial Overview
    • 10.6.5 SWOT Analysis
    • 10.6.6 Key Developments
  • 10.7 Amway Corp
    • 10.7.1 Key Facts
    • 10.7.2 Business Description
    • 10.7.3 Products and Services
    • 10.7.4 Financial Overview
    • 10.7.5 SWOT Analysis
    • 10.7.6 Key Developments
  • 10.8 GSK Plc
    • 10.8.1 Key Facts
    • 10.8.2 Business Description
    • 10.8.3 Products and Services
    • 10.8.4 Financial Overview
    • 10.8.5 SWOT Analysis
    • 10.8.6 Key Developments

11. Appendix

  • 11.1 About The Insight Partners
  • 11.2 Glossary of Terms

List Of Tables

  • Table 1. Middle East & Africa Sarcopenia Treatment Market Segmentation
  • Table 2. Sarcopenia Drug Under Clinical Development
  • Table 3. Middle East & Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million)
  • Table 4. Middle East & Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Treatment Type
  • Table 5. Middle East & Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Million) - By Distribution Channel
  • Table 6. Middle East & Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Country
  • Table 7. South Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Treatment Type
  • Table 8. South Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Distribution Channel
  • Table 9. Saudi Arabia Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Treatment Type
  • Table 10. Saudi Arabia Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Distribution Channel
  • Table 11. United Arab Emirates Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Treatment Type
  • Table 12. United Arab Emirates Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Distribution Channel
  • Table 13. Rest of Middle East & Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Treatment Type
  • Table 14. Rest of Middle East & Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn) - By Distribution Channel
  • Table 15. Recent Inorganic Growth Strategies in the Sarcopenia Treatment Market
  • Table 16. Recent Organic Growth Strategies in the Sarcopenia Treatment Market
  • Table 17. Glossary of Terms, Sarcopenia Treatment Market

List Of Figures

  • Figure 1. Middle East & Africa Sarcopenia Treatment Market Segmentation, By Country
  • Figure 2. Impact Analysis of Drivers and Restraints
  • Figure 3. Middle East & Africa Sarcopenia Treatment Market Revenue (US$ Million), 2020 - 2030
  • Figure 4. Middle East & Africa Sarcopenia Treatment Market Share (%) - By Treatment Type, 2022 and 2030
  • Figure 5. Vitamin D and Calcium Supplement: Middle East & Africa Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 6. Protein Supplement : Middle East & Africa Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 7. Vitamin B12 Supplement: Middle East & Africa Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 8. Others : Middle East & Africa Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 9. Middle East & Africa Sarcopenia Treatment Market Share (%) - By Distribution Channel, 2022 and 2030
  • Figure 10. Pharmacies : Middle East & Africa Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 11. Retail Channels : Middle East & Africa Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 12. Online Channels : Middle East & Africa Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 13. Others : Middle East & Africa Sarcopenia Treatment Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 14. Middle East & Africa Sarcopenia Treatment Market Revenue, by Key Countries, (2022) (US$ Mn)
  • Figure 15. Middle East & Africa Sarcopenia Treatment Market Breakdown by Key Countries, 2022 and 2030 (%)
  • Figure 16. South Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn)
  • Figure 17. Saudi Arabia Sarcopenia Treatment Market - Revenue and Forecast to 2030 (US$ Mn)
  • Figure 18. United Arab Emirates Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 19. Rest of Middle East & Africa Sarcopenia Treatment Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 20. Growth Strategies in the Sarcopenia Treatment Market